Skip to main content

Novan gets boost from latest phase 3 trial results for lead drug

"It's a watershed moment for Novan," the company's CEO told investors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.